Open AccessAutologous adipose‐derived stem cells therapy in COPD treatment: a case report
Author(s) -
Nguyen Thuy Thanh,
Phan Phuong Thu,
Nguyen Binh Huy,
Vu Trang T. Thu,
Pham Phuong Cam,
Van Vu Giap,
Nguyen Khanh Ba,
Vu Trung Thanh,
Vu Luu Dang,
Ngo Chau Quy
Publication year - 2021
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.748
Subject(s) - medicine , adipose tissue , copd , stem cell , bronchodilator , vital capacity , surgery , lung , asthma , lung function , genetics , diffusing capacity , biology
Here, we describe the clinical course of a patient with chronic obstructive pulmonary disease treated with autologous adipose‐derived stem cell therapy. In September 2019, our patient was admitted to Bach Mai Hospital. His post‐bronchodilator forced expiratory volume in 1 sec (FEV 1 ) was 21% and FEV 1 /forced vital capacity (FVC) was 40%. He had suffered from two exacerbations of chronic obstructive pulmonary disease (COPD) in the previous year. He received treatment with autologous stem cells from adipose tissue. Follow‐up indicated that autologous stem cells from adipose tissue was a safe treatment and improved the patient's dyspnoea and quality of life.